A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
about
Antibiotic treatment for Clostridium difficile -associated diarrhea in adultsAmixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistanceTreating Clostridium difficile infection with fecal microbiota transplantationBench-to-bedside review: Clostridium difficile colitisComparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infectionsRecent Advances in the Diagnosis and Treatment of Clostridium Difficile InfectionFidaxomicin: A novel agent for the treatment of Clostridium difficile infectionDisruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic ResistanceGastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infectionEfficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-AnalysisWSES guidelines for management of Clostridium difficile infection in surgical patientsRational Therapy of Clostridium difficile InfectionsClostridium difficile in the ICU: the struggle continuesClostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic reviewPseudomembranous colitisClostridium difficile Infection in Children: Current State and Unanswered QuestionsRecent changes in Clostridium difficile infectionRecurrent Clostridium difficile infections: the importance of the intestinal microbiotaThe potential for emerging therapeutic options for Clostridium difficile infectionSaccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticumGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveTrends in Clostridium difficile Disease: Epidemiology and InterventionPrediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic reviewAntibiotic treatment for Clostridium difficile-associated diarrhoea in adults.Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Clostridium difficile infection: Updates in management.Clostridium difficile Infection and Fecal Microbiota Transplant.Clostridium difficile infection: New insights into therapeutic options.Antibiotic Regimen after a Total Abdominal Colectomy with Ileostomy for Fulminant Clostridium difficile Colitis: A Multi-Institutional Study.Delirium and other clinical factors with Clostridium difficile infection that predict mortality in hospitalized patients.Quantitative Fecal Lactoferrin as a Biomarker for Severe Clostridium difficile Infection in Hospitalized Patients.Clostridium difficile infection: guideline-based diagnosis and treatmentVancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection.Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.Thrombocytopenia in hospitalized patients with severe clostridium difficile infection.Community-acquired Clostridium difficile infection.
P2860
Q24234378-4E695E9C-1D6E-4E57-A0BB-777D91ACA938Q24616179-EC824CD2-F950-40C7-A5BD-8A55A9B8B720Q24632641-E57A2FE7-B08E-4C32-AF43-6EED5632BE29Q24634294-5462454D-57BF-45D9-9A8A-E9F927E038E1Q24644191-FC7C9FBF-9483-4112-AE7A-6D94FFC8D867Q26752760-4047DB64-A93D-464F-84D3-F6B92C0C6674Q26766112-9A9B12BD-381B-4146-9D10-C10280D3E39CQ26770175-194D5F77-E06E-4664-89FD-F2B4615146BAQ26771995-6250DA1F-5CC9-4A95-A0EF-CCAB145B0F45Q26776155-A9D7665C-B49D-4C4D-97D9-8971FDBE8D32Q26786662-6F0968D2-3051-4591-A0C5-4133593E0CADQ26795429-A701E217-AC9C-4C4C-8E27-D6FE5FFE5DF5Q26796548-555B87BA-64CA-4DE6-BE9B-8668785C04ACQ26823000-EF9C28F8-010C-4648-869D-B03E1581D17DQ26827693-1ABA0F69-A67A-4865-830D-5658653A88D1Q26865999-7ABEFA4F-EDE7-467C-9F73-DA5076BF3087Q27016320-6A7A8EE5-CD04-4F13-AC62-CA8B9D5FFD9CQ27022537-625E6382-543A-4644-BBA9-A1E2D61696F4Q27023219-40CFD04B-3CA3-4809-A34C-BDCEA839C672Q28082059-8DA72FE1-BC22-44FD-BE2F-44E1C03B9E83Q28236940-E63C9EFB-0EE6-4BE7-B591-05168B91789BQ28388806-D7A46029-6780-4C1E-B219-028DDF15A2ADQ28655729-065632A6-89FD-4838-BF81-E13CC6F30508Q28732437-8C36345B-5B95-4A8E-B35C-D10DED9892BAQ30235446-920EDAC5-7913-4537-8754-8F4FE4D55D40Q30238945-4B8FF4A3-B792-4C06-B02B-8A563394F905Q30239988-8D4E74B5-B2B5-4982-B29A-AB28D290166BQ30240065-F7F458C1-021D-455A-8226-D0F11B146446Q30252154-DDE3ECA1-D967-433E-92CC-90C33B9687B4Q30279196-8C867C2E-1038-41BB-A8D4-939B5D74DD43Q30300033-8DA9250B-6C7F-4396-BD4B-29EC172F2867Q30301297-2A6EA115-2BE8-4609-8A4B-EF667865DA6AQ30316981-BA41BE42-3D7C-4B90-A564-19E0243DA7B1Q30417830-A333133E-1151-49CA-90E4-312EC4E9E61DQ30423298-EAB81B12-FE89-4DDB-A853-226372EB04B4Q30425705-911C0DA1-C626-4856-AECB-898C0D14697FQ30437722-587FBAC9-5C5C-4C20-BD47-0F7901F86B39Q33398747-AA3566C3-AB47-4AD3-AB7A-B1B442B89A14Q33435292-E899DEB9-A5C7-4F08-AAF0-CB9B3F5948C8Q33574962-611DB37B-F6B7-4643-961A-EFF9054B0273
P2860
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A comparison of vancomycin and ...... tratified by disease severity.
@ast
A comparison of vancomycin and ...... tratified by disease severity.
@en
A comparison of vancomycin and ...... tratified by disease severity.
@nl
type
label
A comparison of vancomycin and ...... tratified by disease severity.
@ast
A comparison of vancomycin and ...... tratified by disease severity.
@en
A comparison of vancomycin and ...... tratified by disease severity.
@nl
prefLabel
A comparison of vancomycin and ...... tratified by disease severity.
@ast
A comparison of vancomycin and ...... tratified by disease severity.
@en
A comparison of vancomycin and ...... tratified by disease severity.
@nl
P2093
P2860
P356
P1476
A comparison of vancomycin and ...... tratified by disease severity.
@en
P2093
Fred A Zar
K M L S T Moorthi
Melinda B Davis
Srinivasa R Bakkanagari
P2860
P304
P356
10.1086/519265
P407
P577
2007-06-19T00:00:00Z